RESUMEN
Protecting group-free synthesis of 1,2:5,6-di-anhydro-D-mannitol, followed by ring opening with propargylamine and subsequent ring closure produced a separable mix of piperidine N-propargyl 1,5-dideoxy-1,5-imino-D-gulitol and azepane N-propargyl 1,6-dideoxy-1,6-imino-D-mannitol. In O-acetylated form, these two building blocks were subjected to CuAAC click chemistry with a panel of three differently azide-substituted glucose building blocks, producing iminosugar pseudo-disaccharides in good yield. The overall panel of eight compounds, plus 1-deoxynojirimycin (DNJ) as a benchmark, was evaluated as prospective inhibitors of almond ß-glucosidase, yeast α-glucosidase and barley ß-amylase. The iminosugar pseudo-disaccharides showed no inhibitory activity against almond ß-glucosidase, while the parent N-propargyl 1,5-dideoxy-1,5-imino-D-gulitol and N-propargyl 1,6-dideoxy-1,6-imino-D-mannitol likewise proved to be inactive against yeast α-glucosidase. Inhibitory activity could be reinstated in the former series by appropriate substitution on nitrogen. The greater activity of the piperidine could be rationalized based on docking studies. Further, potent inhibition of ß-amylase was observed with compounds from both the piperidine and azepane series.
Asunto(s)
Inhibidores Enzimáticos/síntesis química , Compuestos Heterocíclicos con 1 Anillo/síntesis química , Iminoazúcares/síntesis química , Piperidinas/síntesis química , Triazoles/síntesis química , alfa-Glucosidasas/química , beta-Amilasa/química , beta-Glucosidasa/química , 1-Desoxinojirimicina/química , Azidas/química , Química Clic/métodos , Disacáridos/química , Inhibidores Enzimáticos/química , Glucosa/química , Compuestos Heterocíclicos con 1 Anillo/química , Hordeum/química , Hordeum/enzimología , Iminoazúcares/química , Manitol/química , Pargilina/análogos & derivados , Pargilina/química , Piperidinas/química , Propilaminas/química , Prunus dulcis/química , Prunus dulcis/enzimología , Saccharomyces cerevisiae/química , Saccharomyces cerevisiae/enzimología , Triazoles/química , beta-Amilasa/antagonistas & inhibidores , beta-Glucosidasa/antagonistas & inhibidoresRESUMEN
A practical one-pot synthesis of nicotine analogs from Ugi 4-CR/propargyl adducts is reported. This methodology allows the rapid construction of the pyrrolidine moiety present in nicotine through an intramolecular base-promoted 5-endo cycloisomerization process, followed by a reduction of the resulting mixture of 2- and 3-pyrrolines to afford nicotine analogs in good overall yields.
Asunto(s)
Técnicas Químicas Combinatorias/métodos , Nicotina/análogos & derivados , Nicotina/síntesis química , Catálisis , Ciclización , Éteres de Hidroxibenzoatos/química , Estructura Molecular , Nicotina/química , Oxidación-Reducción , Paladio/química , Pargilina/análogos & derivados , Pargilina/química , Propilaminas/química , Piridinas/química , EstereoisomerismoRESUMEN
Herein, we describe an approach toward selenazole preparation based on the cycloisomerization of propargyl selenoamides. The selenoamides were synthesized in situ using the Ishihara reagent with spontaneous cyclization to form the 2,5-disubstituted selenazoles. Heterocylcles 9a-j were prepared using readily available starting materials, and yields ranged from moderate to good (20-80%). Methylselenazole 9a could be transformed into a bromomethyl derivative 13 using NBS. The intermediate 13 would provide a more versatile building block for further derivatizations, e.g., the cyanide 14.
Asunto(s)
Oxígeno/química , Pargilina/análogos & derivados , Pargilina/química , Compuestos de Selenio/síntesis química , Selenio/química , Catálisis , Ciclización , Estructura Molecular , Compuestos de Selenio/químicaRESUMEN
Our aim was to study the specific role of the postsynaptic D(1) receptors on dopaminergic response and analyze the metabolized dopamine (DA) in the rat striatum. We used male Wistar rats to evaluate the effects of different doses of a D(1) agonist (SKF-38393) and a D(1) antagonist (SCH-23390), and their co-administration. The levels of DA and L-3, 4-dihydroxyphenylacetic acid (DOPAC) were measured using high performance liquid chromatography. The systemic injection of SKF-38393 alone at 1, 5 and 10 mg/kg did not alter the DA and DOPAC levels or the DOPAC/DA ratio. In contrast, injection of SCH-23390 alone at 0.25, 0.5 and 1 mg/kg significantly increased the DA and DOPAC levels, as well as the DOPAC/DA ratio, compared with the respective control groups. The co-administration of SCH-23390+SKF-38393 did not alter the DA or DOPAC levels, but it did significantly inhibit the SCH-23390-induced increase of the DA and DOPAC levels. The SCH-23390+SKF-38393 and the SCH-23390-only groups showed an increase in the DOPAC/DA ratio. The co-administration of SCH-23390+PARGYLINE significantly decreased the DOPAC levels and the DOPAC/DA ratio compared with the control and SCH-23390 groups. Taken together, our results showed that selective inhibition with SCH-23390 produced an increase in metabolized DA via striatal monoamine oxidase. These findings also contribute to the understanding of the role of postsynaptic D(1) receptors in the long-loop negative feedback system in the rat striatum.
Asunto(s)
Ácido 3,4-Dihidroxifenilacético/metabolismo , Cuerpo Estriado/efectos de los fármacos , Dopamina/metabolismo , Receptores de Dopamina D1/antagonistas & inhibidores , 2,3,4,5-Tetrahidro-7,8-dihidroxi-1-fenil-1H-3-benzazepina/administración & dosificación , 2,3,4,5-Tetrahidro-7,8-dihidroxi-1-fenil-1H-3-benzazepina/farmacología , Animales , Benzazepinas/administración & dosificación , Benzazepinas/farmacología , Cuerpo Estriado/metabolismo , Agonistas de Dopamina/farmacología , Antagonistas de Dopamina/farmacología , Masculino , Pargilina/administración & dosificación , Ratas , Ratas WistarRESUMEN
RATIONALE: The transition to menopause is associated with an increased risk of depressed mood. OBJECTIVES: This study was conducted to investigate whether diphenyl diselenide [(PhSe)2] treatment could reduce the effects of postmenopausal depression-like behavior in ovariectomized female mice submitted to subchronic stress exposure. METHODS: Mice were divided into four groups: sham, (PhSe)2, ovariectomy (OVX), and OVX + (PhSe)2. Animals were ovariectomized/sham-operated and subjected to stress session once a day for 7 days from the fifth to the 11th day after OVX. The behavioral tests (open field, tail suspension (TST), and forced swimming (FST)) were performed on the 14th day after OVX. Mice were treated orally once a day with vehicle (canola oil, 10 ml/kg) or (PhSe)2 (10 mg/kg; 10 ml/kg) 30 min before being exposed to subchronic stress, or from the 11th to the 14th day. Paroxetine (8 mg/kg i.p.) and pargyline (30 mg/kg i.p.) were used as positive controls. The involvement of serotonergic receptor subtypes in the antidepressant-like effect of (PhSe)2 was assessed in the FST using WAY 100635 (0.1 mg/kg s.c.), ritanserin (1 mg/kg i.p.), and ondansetron (1 mg/kg i.p.) as serotonergic antagonists. Monoamine oxidase (MAO) A and B activities were also determined. RESULTS: The prolongation of immobility time in TST and FST in OVX mice submitted to subchronic stress was prevented by (PhSe)2 treatment. Ritanserin and ondansetron blocked the antidepressive-like effect of (PhSe)2, suggesting the involvement of 5-HT(2A/2C) and 5-HT3 receptor subtypes. Both paroxetine and pargyline were effective in reducing the immobility time of stressed OVX mice in the FST. No alterations in locomotor activity were observed. Although (PhSe)2 had inhibited in vitro MAO-A and MAO-B activities, none of the groups presented alterations neither in ex vivo MAO-A nor in MAO-B activity. CONCLUSIONS: (PhSe)2 treatment could influence mood and behavior, indicating a promising role of this organoselenium compound in the management of postmenopausal depressive symptoms.
Asunto(s)
Derivados del Benceno/uso terapéutico , Depresión/enzimología , Menopausia/fisiología , Compuestos de Organoselenio/uso terapéutico , Ovariectomía/psicología , Neuronas Serotoninérgicas/efectos de los fármacos , Neuronas Serotoninérgicas/enzimología , Estrés Psicológico/tratamiento farmacológico , Animales , Antidepresivos/uso terapéutico , Derivados del Benceno/antagonistas & inhibidores , Derivados del Benceno/farmacología , Corteza Cerebral/efectos de los fármacos , Corteza Cerebral/enzimología , Depresión/complicaciones , Depresión/tratamiento farmacológico , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Interacciones Farmacológicas , Femenino , Hipocampo/efectos de los fármacos , Hipocampo/enzimología , Pérdida de Tono Postural/efectos de los fármacos , Ratones , Ratones Endogámicos , Mitocondrias/enzimología , Monoaminooxidasa/metabolismo , Inhibidores de la Monoaminooxidasa/farmacología , Inhibidores de la Monoaminooxidasa/uso terapéutico , Ondansetrón/farmacología , Compuestos de Organoselenio/antagonistas & inhibidores , Compuestos de Organoselenio/farmacología , Pargilina/farmacología , Pargilina/uso terapéutico , Paroxetina/farmacología , Paroxetina/uso terapéutico , Piperazinas/farmacología , Piridinas/farmacología , Ritanserina , Antagonistas de la Serotonina/farmacología , Estrés Psicológico/complicaciones , Estrés Psicológico/enzimologíaRESUMEN
A series of 4-amino-7-chloroquinoline derivatives were synthesized by the reaction of 4,7-dichloro-quinoline with the corresponding diamine and then with propargyl bromide. In addition, platinum(II) complexes were obtained by reacting some of the organic derivatives with K(2)PtCl(4). Several of the synthesized compounds displayed antituberculosis activities. Compound 3 was 47.5 times more active than amphotericin B against Leishmania chagasi (IC(50)=0.04 µg/mL). Compounds 5, 6, 7, 9, 10, 11 and 13 presented promising results against Mycobacterium tuberculosis, with MIC values ranging from 12.5 to 15.6 µg/mL, comparable to the "first and second line" drugs used to treat tuberculosis.
Asunto(s)
Aminoquinolinas/síntesis química , Aminoquinolinas/farmacología , Antituberculosos/síntesis química , Complejos de Coordinación/síntesis química , Complejos de Coordinación/farmacología , Leishmania/efectos de los fármacos , Platino (Metal)/química , Aminoquinolinas/química , Anfotericina B/farmacología , Antituberculosos/química , Antituberculosos/farmacología , Complejos de Coordinación/química , Diaminas/química , Pruebas de Sensibilidad Microbiana/métodos , Mycobacterium tuberculosis/efectos de los fármacos , Pargilina/análogos & derivados , Pargilina/químicaRESUMEN
Long-chain polyacetylene alcohols, faulknerynes A-C, along with known compounds diplynes A, C and E, were isolated from two specimens of the encrusting sponge, Diplastrella sp., collected from the surface of coral in the Bahamas. Two CD methods were critically evaluated for their suitability to terminal propargylic glycols and applied to assignment of configurations of faulkneryne A and diplyne C.
Asunto(s)
Pargilina/química , Poliinos/química , Poríferos/química , Animales , Antozoos/química , Bahamas , Dicroismo Circular/métodos , Espectroscopía de Resonancia por Spin del Electrón , Espectroscopía de Resonancia Magnética , Estructura Molecular , Poliinos/aislamiento & purificaciónRESUMEN
The neurons that produce gonadotrophin-releasing hormone (GnRH) are mainly found in the medial preoptic area (MPOA) and constitute a common final pathway to the control of luteinizing hormone (LH) surge on proestrus. The control of GnRH secretion depends on several neurotransmitters, such as serotonin (5-HT), noradrenaline (NA), dopamine (DA) and nitric oxide (NO). The aim of this work was to study the profile of 5-HT, catecholamines and their main metabolites in the MPOA throughout the estrous cycle and their interactions with NO system in this area to control LH surge. For this purpose, the following were evaluated: (I) the effect of pargyline (a monoamine oxidase inhibitor) acute treatment on plasma LH secretion throughout the estrous cycle, correlated with changes of 5-HT, DA and NA content as well as activity and expression of neuronal NO synthase (nNOS) within MPOA; (II) the effect of 5,7-dihydroxitriptamine (a drug that depletes 5-HT) microinjection into MPOA on plasma LH in ovariectomized rats treated with oil, estradiol (E(2)) or E(2) plus progesterone (P(4)). Pargyline prevented LH surge on proestrus without altering its basal secretion. Throughout the estrous cycle, pargyline augmented both 5-HT and DA contents in approximately 300% and NA content in 50% in the MPOA. During proestrus, pargyline stimulated nNOS activity at 9 h and inhibited it at 11 h. nNOS expression was inhibited by pargyline at 15 h. Depletion of 5-HT content in the MPOA increased LH secretion in ovariectomized rats treated with E(2) plus P(4), but it did not modify in rats treated with either oil or E(2). Therefore, the present data show that pargyline treatment can inhibit proestrus LH surge through a mechanism that may involve 5-HT and NO systems in the MPOA. Moreover, the effect of 5-HT in the MPOA for limiting LH surge seems to depend on plasma levels of E(2) and P(4).
Asunto(s)
Monoaminas Biogénicas/metabolismo , Ciclo Estral/efectos de los fármacos , Hormona Luteinizante/metabolismo , Inhibidores de la Monoaminooxidasa/farmacología , Óxido Nítrico/metabolismo , Pargilina/farmacología , Área Preóptica/efectos de los fármacos , 5,7-Dihidroxitriptamina/farmacología , Análisis de Varianza , Animales , Femenino , Ovariectomía/métodos , Radioinmunoensayo/métodos , Ratas , Ratas Wistar , Serotoninérgicos/farmacologíaRESUMEN
The purpose of this study was to determine the basal levels of dopamine (DA) and to examine the enzymes involved in DA metabolism in different microdissected nephron segments from rat kidneys. Segments were incubated with DA (50 nM) or DA plus monoamine oxidase (MAO) or catechol-O-methyl transferase (COMT) inhibitors. Basal DA levels were higher in the proximal convoluted tubule (PCT, 10.8+/-3.7 pg/mm) and in the medullary collecting duct (MCD, 10.9+/-4.0 pg/mm) than in the medullary thick ascending limb of Henle's loop (MTAL, 4.9+/-0.9 pg/mm) (P<0.05). The percentage of exogenously added DA that was not metabolised was similar in both PCT (67+/-13%) and MCD (65+/-5%) and lower in MTAL (35+/-7%), suggesting that MTAL is a major site of DA metabolism. Inhibition of MAO (pargyline 1 mM) significantly increased the basal content of DA and the percentage of the added non-metabolised DA (to 95+/-10%) in PCT but had no effect on MTAL or MCD. Conversely, inhibition of COMT (nitecapone or Ro-41-0960, both 1 mM) slightly increased the basal levels of DA only in MTAL, whereas the percentage of added DA not metabolised rose to 97+/-10% in MTAL and to 91+/-15% in MCD. COMT inhibition had no effect in PCT. In conscious rats pargyline (50 mg/kg) increased urinary DA from 680+/-34 to 1,128+/-158 ng/d/100 g BW (P<0.01) while nitecapone (40 mg/kg) produced a slight non-significant increment. Our results show that DA is present all along the rat nephron and that renal DA is metabolised continuously and predominantly by MAO in proximal segments, and by COMT in the more distal ones.
Asunto(s)
Dopamina/metabolismo , Nefronas/enzimología , Animales , Benzofenonas/farmacología , Catecol O-Metiltransferasa/metabolismo , Inhibidores de Catecol O-Metiltransferasa , Catecoles/farmacología , Corteza Renal/enzimología , Médula Renal/enzimología , Túbulos Renales Colectores/enzimología , Túbulos Renales Proximales/enzimología , Asa de la Nefrona/enzimología , Masculino , Monoaminooxidasa/metabolismo , Inhibidores de la Monoaminooxidasa/farmacología , Natriuresis/efectos de los fármacos , Pargilina/farmacología , Pentanonas/farmacología , Ratas , Ratas WistarRESUMEN
The concentration of dopamine, and its metabolites 3,4-dihydroxyphenylacetic and homovanillic acids, as well as serotonin and its metabolite 5-hydroxyindoleacetic acid, were determined in the retina of two teleosts, C. auratus (goldfish) and E. plumieri (mojarra), and two mammals, R. norvegicus (rat) and O. cuniculus (rabbit). The turnover rate of these monoamines were investigated in the four species by the calculation of the ratio monoamine/metabolite as an indirect index, and in goldfish and rat by the inhibition of the synthesis with alpha-methyl-p-tyrosine or p-chlorophenylalanine, by the increase in dopamine or serotonin by the corresponding precursors, 3,4-dihydroxyphenylalanine or 5-hydroxytryptophan, and by inhibition of monoaminooxidase with pargyline. The modulation by light and dark stimulation was studied in the goldfish and the rat. Differences in the concentration and turnover rate were observed among the species. Serotonin concentration was higher in the teleosts. The administration of inhibitors of dopamine and serotonin synthesis differentially decreased the levels of the monoamines in the retina of goldfish and rat. The rate of formation of dopamine and serotonin by the corresponding precursors was much higher in the goldfish than in the rat. Pargyline administration decreased 3,4-dihydroxyphenylacetic and 5-hydroxyindoleacetic acids at different rates and time dependency in the retina of goldfish and rat. Dopamine and serotonin concentration did not exhibit high modifications by the inhibitor, suggesting the function of regulatory mechanisms or additional effect of pargyline at other sites different from monoaminooxidase.(ABSTRACT TRUNCATED AT 250 WORDS)
Asunto(s)
Dopamina/metabolismo , Carpa Dorada/metabolismo , Luz , Perciformes/metabolismo , Conejos/metabolismo , Ratas/metabolismo , Retina/metabolismo , Serotonina/metabolismo , Ácido 3,4-Dihidroxifenilacético/metabolismo , 5-Hidroxitriptófano/farmacología , Animales , Carbidopa/farmacología , Fenclonina/farmacología , Ácido Homovanílico/metabolismo , Ácido Hidroxiindolacético/metabolismo , Levodopa/farmacología , Masculino , Metiltirosinas/farmacología , Pargilina/farmacología , Ratas Sprague-Dawley , Retina/efectos de la radiación , Especificidad de la Especie , alfa-MetiltirosinaRESUMEN
The present work was addressed to study a possible relationship between monoamine oxidase (MAO) and the thyroid iodide transport mechanism. Normal rats treated with clorgyline (a selective MAO-A inhibitor) or tranylcypromine (a non-selective MAO inhibitor) showed a significantly diminished thyroid MAO activity, while deprenyl and pargyline (MAO-B inhibitors) did not modify the thyroidal enzyme activity with respect to the control group. Under these conditions, in vivo iodide transport was reduced both by clorgyline and tranylcypromine administration whereas it remained unchanged after treatment with MAO-B inhibitors. The effect of MAO inhibitors on thyroid MAO activity and in vivo iodide transport was also evaluated in rats treated with exogenous thyrotrophin (TSH) after endogenous TSH secretion blockade produced by T4 administration. In this condition, thyroid MAO activity was significantly lowered by clorgyline and was not modified by deprenyl. In contrast to the results observed in normal rats, in vivo iodide transport in TSH-treated rats remained unaltered after treatment either with clorgyline or deprenyl. MAO activity evaluated in bovine thyroid follicles in primary culture was highly sensitive to low concentrations of clorgyline (< 10 nmol/l) and relatively insensitive to deprenyl, a finding that indicates a predominance of the MAO-A isoform in the follicular cells in culture. When clorgyline (0.1 and 1 mumol/l) or deprenyl (1 mumol/l) were added to the culture medium, no modifications in the active transport of iodide were observed. These results indicate the absence of a direct linkage between thyroid MAO activity and the active iodide transport.(ABSTRACT TRUNCATED AT 250 WORDS)
Asunto(s)
Yoduros/metabolismo , Inhibidores de la Monoaminooxidasa/farmacología , Monoaminooxidasa/metabolismo , Glándula Tiroides/metabolismo , Animales , Transporte Biológico/efectos de los fármacos , Clorgilina/farmacología , Masculino , Técnicas de Cultivo de Órganos , Pargilina/farmacología , Ratas , Ratas Wistar , Selegilina/farmacología , Glándula Tiroides/efectos de los fármacos , Tranilcipromina/farmacologíaRESUMEN
The duodenal transfer and metabolism of [3H]tyramine from sacs and perfused segments of rat intestine were determined. In sacs, a linear relationship between the steady-state transfer rate of total tritium and the initial mucosal tyramine concentration was observed, suggesting that the clearance is the same at different concentrations. In duodenal perfusions, there was no significant difference in the amount of total tritium removed between control and everted tissues, whether the flow was 0.2 or 2.0 mL/min. The percentage of [3H]tyramine extracted from the gut lumen depended on the flow rate. About 30-40% of the extracted drug was metabolized; this value decreased to 20% when the rats were pretreated with pargyline. The data support the idea that the transfer mechanism for tyramine is simple diffusion.
Asunto(s)
Mucosa Intestinal/metabolismo , Tiramina/farmacocinética , Animales , Fenómenos Químicos , Química Física , Difusión , Duodeno/efectos de los fármacos , Duodeno/enzimología , Duodeno/metabolismo , Técnicas In Vitro , Absorción Intestinal/efectos de los fármacos , Mucosa Intestinal/efectos de los fármacos , Mucosa Intestinal/enzimología , Intestinos/efectos de los fármacos , Intestinos/enzimología , Masculino , Monoaminooxidasa/metabolismo , Pargilina/farmacología , Perfusión , Ratas , Ratas Wistar , Tiramina/metabolismoRESUMEN
Many reports indicate that serotonin plays a role in the regulation of the hypothalamo-pituitary-adrenocortical axis. The present study was designed to elucidate whether the activation of the central serotonergic pathway enhances adrenocorticotropin and corticosterone secretion, and if so, whether the CRH and vasopressin neuronal systems could be mediating this effect. Intraperitoneal administration of a low dose of L-5-hydroxytryptophan (an aromatic L-amino acid precursor of serotonin synthesis; 20 mg/kg bw, 30 minutes before the sacrifice) in rats pretreated with pargyline (a brain monoamine oxidase inhibitor, which enhances monoamine activity; 75 mg/Kg bw, 16 hours before the sacrifice) and carbidopa (a peripheral active inhibitor of the decarboxylation of aromatic L-amino acids, which would permit more monoamine precursor to be available to the brain; 50 mg/Kg bw, 90 minutes before the sacrifice) increased ACTH and corticosterone secretion in plasma. Such an effect was partially blocked by metergoline (a serotonin type-1 and-2 receptor blocker; 1 mg/Kg bw, 90 minutes before the sacrifice), but not by spiperone (a serotonin type-2 and dopamine receptor antagonist; 0.5 mg/Kg bw. 90 minutes before the sacrifice). The activation of the central serotonergic system enhanced the CRH content in the median eminence, whereas it decreased the content of this neuropeptide in the medial basal hypothalamus. These effects were fully abolished by metergoline, but not by spiperone pretreatment. The activation of the serotonergic pathway did not influence the vasopressinergic neuronal system. In vitro experiments using hypothalamic-median eminence fragments incubated with serotonin solutions indicate that this monoamine possesses a CRH releasing effect at concentrations of 1 microM or more.(ABSTRACT TRUNCATED AT 250 WORDS)
Asunto(s)
Corteza Suprarrenal/fisiología , Hormona Liberadora de Corticotropina/fisiología , Hipotálamo/fisiología , Hipófisis/fisiología , Serotonina/fisiología , Vasopresinas/fisiología , 5-Hidroxitriptófano/farmacología , Corteza Suprarrenal/efectos de los fármacos , Hormona Adrenocorticotrópica/sangre , Animales , Carbidopa/farmacología , Corticosterona/sangre , Hipotálamo/efectos de los fármacos , Masculino , Metergolina/farmacología , Pargilina/farmacología , Hipófisis/efectos de los fármacos , Ratas , Ratas Endogámicas , Espiperona/farmacologíaRESUMEN
Effects of angiotensin II (AII) on norepinephrine (NE) catabolism in hypothalamus and medulla oblongata of male rats were studied. 3H-NE uptake, 3H-NE/3H-NE metabolites ratio (NE/MET) and monoamineoxidase (MAO) activity were measured in vitro in both organs. Lack of circulating AII was elicited by means of 48 h bilateral nephrectomy. Pargyline and bilateral nephrectomy increased NE uptake and NE/MET ratio, while in nephrectomized plus pargyline treated groups and additive effect on these results was observed in both organs. All decreased the NE/MET ratio. Pargyline reversed the latter effects of AII. The peptide increased MAO activity in both organs, while bilateral nephrectomy decreased the activity of the enzyme. The results showed that AII modulates NE catabolism by means of MAO activity, eventually at the presynaptic noradrenergic ending sites in the central nervous system.
Asunto(s)
Angiotensina II/farmacología , Hipotálamo/metabolismo , Bulbo Raquídeo/metabolismo , Nefrectomía , Norepinefrina/metabolismo , Animales , Hipotálamo/efectos de los fármacos , Masculino , Bulbo Raquídeo/efectos de los fármacos , Monoaminooxidasa/metabolismo , Pargilina/farmacología , Ratas , Ratas EndogámicasRESUMEN
The influence of inhibitors of metabolism and uptake of noradrenaline on the 3H-noradrenaline removal from the perfusion fluid by the isolated rat liver was studied. Livers were perfused with 3 nmol/l 3H-noradrenaline and 3H-noradrenaline and 3H-metabolites were determined in effluent, liver and bile. After the perfusion with 14,900 +/- 920 dpm.g-1.min-1 during 90 min, cumulative removal of tritium was 323,574 +/- 63,103 dpm/g. 3H-metabolites recovered from the liver after 90 min perfusion represented 71.1 +/- 9.0% of total metabolite formation. Only the OMDA-fraction appeared in the perfusate; its approach to steady state of efflux was slow. The inhibition either of MAO or COMT changed neither the total removal of tritium nor the 3H-metabolites recovered from the liver. Cocaine (10 mumol/l) reduced the accumulation of 3H-noradrenaline in the liver. The uptake2 inhibitor corticosterone (30 mumol/l) diminished total removal of tritium and the 3H-metabolites recovered from the liver without changing the accumulation of 3H-noradrenaline. The hypothesis of two different compartments, one responsible for the metabolism and the other for the accumulation of the amine is discussed.
Asunto(s)
Hígado/metabolismo , Norepinefrina/metabolismo , Animales , Bilis/efectos de los fármacos , Bilis/metabolismo , Inhibidores de Catecol O-Metiltransferasa , Cocaína/farmacología , Corticosterona/farmacología , Técnicas In Vitro , Masculino , Inhibidores de la Monoaminooxidasa/farmacología , Pargilina/farmacología , Perfusión , Ratas , Ratas EndogámicasRESUMEN
The turnover of serotonin (5HT) was determined in the raphe area and cortex of mice infected with Pixuna, a strain of intermediate virulence of Venezuelan equine encephalomyelitis virus (VEEV). NMRI-mice, 24 days old, were inoculated intracerebrally (ic) with 300 LD50 of the virus. The animals were sacrificed 4, 7, 15, 21, 30, and 60 days postinoculation. 5HT and 5-hydroxyindoleacetic acid (5HIAA) in raphe and cortex were determined by high performance liquid chromatography (HPLC) with electrochemical detection. Turnover rate of 5HT was determined by the administration of pargyline, p-chlorophenylalanine, and probenecid. The content of 5HT or 5HIAA and 5HT/5HIAA ratios were not significantly different in infected compared with control mice. However, a decrease of 5HT turnover rate, determined after pargyline treatment, was observed in the raphe and not in the cortex of infected mice at 4 and 7 days after the inoculation. The turnover rate/(5HT)0 in raphe is decreased in infected mice with signs of illness, suggesting a lower density of 5HT innervation in this brain area. The administration of p-chlorophenylalanine and probenecid showed that the cortex is also affected, but the synthesis is less modified than metabolism or elimination. Cell bodies of 5HT neurons seem to be more susceptible than projections to infection by Pixuna strain of VEEV.
Asunto(s)
Corteza Cerebral/metabolismo , Encefalomielitis Equina/metabolismo , Encefalomielitis Equina Venezolana/metabolismo , Núcleos del Rafe/metabolismo , Serotonina/metabolismo , Animales , Corteza Cerebral/efectos de los fármacos , Cricetinae , Fenclonina/farmacología , Ácido Hidroxiindolacético/metabolismo , Masculino , Ratones , Pargilina , Probenecid/farmacología , Núcleos del Rafe/efectos de los fármacos , Factores de TiempoRESUMEN
The concentration and localization of serotonin was determined in the retina of the teleost Eugerres plumieri by using high performance liquid chromatography (HPLC) and immunohistochemical techniques. Serotonin and dopamine were measured simultaneously, their concentrations in the retina being 77 +/- 8 and 516 +/- 23 ng/mg tissue respectively. Treatment of the animals with pargyline significantly increased the levels of dopamine and serotonin. When retinas were treated with the neurotoxin 5,6-dihydroxytryptamine, the level of serotonin was reduced by more than 90% while the dopamine content only diminished by 20% when compared to controls. By using immunohistochemistry with a monoclonal anti-serotonin antibody it was possible to localize this amine in cell bodies of a population of amacrine cells with processes extending mainly into a thin layer of the most external lamina of the inner plexiform layer. Very few ramifications were seen projecting to the internal lamina of this layer. When visualized in flat mount preparations, dense arborization of fluorescent processes was observed. This is the first direct evidence that serotonin is apparently present in amacrine cells of the retina of E. plumieri with a distribution of the serotonergic terminals similar to goldfish but somewhat different when compared to other species.
Asunto(s)
Peces/metabolismo , Retina/metabolismo , Serotonina/metabolismo , 5,6-Dihidroxitriptamina/farmacología , Animales , Cromatografía Líquida de Alta Presión , Dopamina/metabolismo , Inmunohistoquímica , Neuronas/metabolismo , Pargilina/farmacología , Retina/citología , Retina/efectos de los fármacosRESUMEN
Ethylephrine, assayed in isolated rat atria, as a dose-chronotropic response curve showed a typical bell-dome shape of the sympathomimetic amines. Yet, on the same basis, it was less powerful than epinephrine, norepinephrine or isoproterenol. Pretreatment with reserpine provoked supersensitivity and increase in the maximum. As well, previous administration of pargyline to the animals resulted in augmented accelerating effects, either in normal or reserpinized preparations. Cocaine or phentolamine shifted the dose-response curve to the left. On the contrary, propranolol, produced a marked action, decelerating the effects of ethylephrine and also decreased the maxima with higher doses. It is concluded that ethylephrine: a) is a direct-acting sympathomimetic amine; b) it brings beta-receptor stimulation; c) a certain degree of alpha-receptor decelerating effect is also involved; d) it is a good substrate of monoaminoxidase.
Asunto(s)
Etilefrina/farmacología , Sistema de Conducción Cardíaco/efectos de los fármacos , Frecuencia Cardíaca/efectos de los fármacos , Monoaminooxidasa/farmacología , Fenilefrina/análogos & derivados , Simpatomiméticos/farmacología , Animales , Cocaína/farmacología , Relación Dosis-Respuesta a Droga , Femenino , Atrios Cardíacos/efectos de los fármacos , Masculino , Contracción Miocárdica/efectos de los fármacos , Pargilina/farmacología , Propranolol/farmacología , Ratas , Receptores Adrenérgicos alfa/efectos de los fármacos , Receptores Adrenérgicos beta/efectos de los fármacos , Estimulación QuímicaRESUMEN
5-hydroxytryptamine (serotonin) produces a positive chronotropic effect in the isolated atrium of the hamster. The characterization of this effect using reserpine pretreatment, propranolol, pargyline, 6-hydroxydopamine or the combination of some of those drugs enable us to conclude that serotonin is an amine of mixed action in the isolated atrium of the hamster, that is, its positive chronotropic effect has a direct component, which is obtained with lower concentrations of agonist and an indirect component through the liberation of endogenous noradrenaline from the sympathetic nerve terminals. The highest concentrations of serotonin are responsible of that component. Pargyline potentiates the indirect component of 5-HT, because inhibition of intraneuronal monoamine oxidase (MAO) avoids the degradation of the noradrenaline released, but it does not potentiate the direct component, indicating that postsynaptic cardiac MAO has little importance in the metabolism of serotonin administered exogenously.